OMRX — Orthometrix Share Price
Last trade - 00:00Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | -37.72% | ||
Financial Summary
| Year End 31st Dec | Unit | 2003 | 2004 | 2005 | 2006 | 2007 | 2008E | 2009E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 1.57 | 1.18 | 1.51 | 2.36 | 2.41 | n/a | n/a | 21.72% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Orthometrix, Inc. markets, sells and services several musculoskeletal product lines used in pharmaceutical research, diagnosis and monitoring of bone and muscle disorders, sports medicine, rehabilitative medicine, physical therapy and pain management. The Company offers five product lines. The Company markets, sells and services its products primarily in the United States and Canada. It markets, sells and services its products and devices through two divisions: Healthcare Division and Sports & Fitness Division. The Sports & Fitness Division markets, sells and services the exercise systems, which include the Mini VibraFlex, Mini VibraFlex Plus, VibraFlex 550, among others. The Healthcare Division markets, sells and services include pQCT bone and muscle measurement systems for use in musculoskeletal research applications.
Directors
- Reynald Bonmati CHM (65)
- Neil Koenig CFO (60)
- Michael Huber DRC (85)
- Andre-Jacques Neusy DRC (69)
- William Orr DRC (73)
- Albert Waxman DRC
- Last Annual
- December 31st, 2007
- Last Interim
- September 30th, 2008
- Incorporated
- December 21st, 1993
- Public Since
- November 3rd, 1998
- No. of Shareholders
- 93
- No. of Employees
- 7
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 53,416,864
- Address
- 5621 Strand Blvd Ste 111, NAPLES, 34110-7302
- Web
- Phone
- +1 3026587581
- Auditors
- Radin, Glass & Co. LLP
Similar to OMRX
Aamaxan Transport
Pink Sheets on Nasdaq
ACCUSTEM SCIENCES
Pink Sheets on Nasdaq
ADM Tronics Unlimited
Pink Sheets on Nasdaq
Advanced Biomedical Technologies
Pink Sheets on Nasdaq
Aksys
Pink Sheets on Nasdaq
FAQ
As of Today at 19:16 UTC, shares in Orthometrix are trading at $0.00. This share price information is delayed by 15 minutes.
Shares in Orthometrix last closed at $0.00 and the price had moved by -99% over the past 365 days. In terms of relative price strength the Orthometrix share price has underperformed the S&P500 Index by -99.14% over the past year.
There is no consensus recommendation for this security.
Orthometrix does not currently pay a dividend.
Orthometrix does not currently pay a dividend.
Orthometrix does not currently pay a dividend.
To buy shares in Orthometrix you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.00, shares in Orthometrix had a market capitalisation of .
Here are the trading details for Orthometrix:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: OMRX
Based on an overall assessment of its quality, value and momentum Orthometrix is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Orthometrix. Over the past six months, its share price has underperformed the S&P500 Index by -16.56%.
As of the last closing price of $0.00, shares in Orthometrix were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Orthometrix PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Orthometrix's management team is headed by:
- Reynald Bonmati - CHM
- Neil Koenig - CFO
- Michael Huber - DRC
- Andre-Jacques Neusy - DRC
- William Orr - DRC
- Albert Waxman - DRC